SUVRETTA CAPITAL MANAGEMENT LLC 13D and 13G filings for Monte Rosa Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-16 5:30 pm Purchase | 2025-04-09 | 13G | Monte Rosa Therapeutics, Inc. GLUE | SUVRETTA CAPITAL MANAGEMENT LLC | 3,360,000 5.500% | 3,360,000 (New Position) | Filing |